Evidence map›Paper›PMID 26738539›Full record

ArticleBlood2016

Arf6 controls platelet spreading and clot retraction via integrin αIIbβ3 trafficking.

Yunjie Huang, Smita Joshi, Binggang Xiang, Yasunori Kanaho, Zhenyu Li, Beth A Bouchard, Carole L Moncman, Sidney W Whiteheart

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The winding road to platelet α-granules.Frontiers in cell and developmental biology · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Factor IX(a) inhibitors: an updated patent review (2003-present).Expert opinion on therapeutic patents · 2022
    Review
  16. Review
  17. In and out: Traffic and dynamics of thrombopoietin receptor.Journal of cellular and molecular medicine · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yunjie HuangDepartment of Molecular and Cellular Biochemistry and.
Smita JoshiDepartment of Molecular and Cellular Biochemistry and.
Binggang XiangDivision of Cardiovascular Medicine, Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY;
Yasunori KanahoDepartment of Physiological Chemistry, University of Tsukuba, Tsukuba, Ibaraki, Japan; and.
Zhenyu LiDivision of Cardiovascular Medicine, Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY;
Beth A BouchardDepartment of Biochemistry, University of Vermont, Burlington, VT.
Carole L MoncmanDepartment of Molecular and Cellular Biochemistry and.
Sidney W WhiteheartDepartment of Molecular and Cellular Biochemistry and.
University of Kentucky · USUniversity of Tsukuba · JPUniversity of Vermont · US

Funding

UNDERSTANDING THE MOLECULAR BASIS OF EPIGENETIC TRANSCRIPTIONAL SILENCINGP20RR020171 · NCRR · UNIVERSITY OF KENTUCKY · PI LOUIS HERSH, LOUIS HERSH LOUIS HERSH · 2004 to 2011
$16.5M
MOLECULAR MECHANISMS OF PLATELET EXOCYTOSISR01HL056652 · NHLBI · UNIVERSITY OF KENTUCKY · PI WHITEHEART, SIDNEY WALDO · 1996 to 2019
$5.2M
The roles of protein kinase G in platelet activationR01HL068819 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DU, XIAOPING · 2002 to 2009
$2.8M
Crosstalk Between Membrane Traffic Proteins and Integrin ActivationR01HL123927 · NHLBI · UNIVERSITY OF KENTUCKY · PI LI, ZHENYU · 2014 to 2017
$1.6M
Platelet Endocytosis in Innate ImmunityR01HL138179 · NHLBI · UNIVERSITY OF KENTUCKY · PI WHITEHEART, SIDNEY WALDO · 2017 to 2019
$1.3M
NCRR NIH HHS P20 RR020171NHLBI NIH HHS HL082193NHLBI NIH HHS HL56652NHLBI NIH HHS HL68819NHLBI NIH HHS L40 HL082193NHLBI NIH HHS R01 HL056652NHLBI NIH HHS R01 HL068819NHLBI NIH HHS R01 HL123927NHLBI NIH HHS R01 HL138179
6 · The paper itself

Abstract

Platelet and megakaryocyte endocytosis is important for loading certain granule cargo (ie, fibrinogen [Fg] and vascular endothelial growth factor); however, the mechanisms of platelet endocytosis and its functional acute effects are understudied. Adenosine 5'-diphosphate-ribosylation factor 6 (Arf6) is a small guanosine triphosphate-binding protein that regulates endocytic trafficking, especially of integrins. To study platelet endocytosis, we generated platelet-specific Arf6 knockout (KO) mice. Arf6 KO platelets had less associated Fg suggesting that Arf6 affects αIIbβ3-mediated Fg uptake and/or storage. Other cargo was unaffected. To measure Fg uptake, mice were injected with biotinylated- or fluorescein isothiocyanate (FITC)-labeled Fg. Platelets from the injected Arf6 KO mice showed lower accumulation of tagged Fg, suggesting an uptake defect. Ex vivo, Arf6 KO platelets were also defective in FITC-Fg uptake and storage. Immunofluorescence analysis showed initial trafficking of FITC-Fg to a Rab4-positive compartment followed by colocalization with Rab11-positive structures, suggesting that platelets contain and use both early and recycling endosomes. Resting and activated αIIbβ3 levels, as measured by flow cytometry, were unchanged; yet, Arf6 KO platelets exhibited enhanced spreading on Fg and faster clot retraction. This was not the result of alterations in αIIbβ3 signaling, because myosin light-chain phosphorylation and Rac1/RhoA activation were unaffected. Consistent with the enhanced clot retraction and spreading, Arf6 KO mice showed no deficits in tail bleeding or FeCl3-induced carotid injury assays. Our studies present the first mouse model for defining the functions of platelet endocytosis and suggest that altered integrin trafficking may affect the efficacy of platelet function.

Indexed as

ADP-Ribosylation Factor 6ADP-Ribosylation FactorsAnimalsBiotinylationBlood PlateletsCell MembraneCell SizeClot RetractionCytoplasmic GranulesEndocytosisFibrinogenHumansMiceMice, KnockoutMice, TransgenicPlatelet Glycoprotein GPIIb-IIIa ComplexADP-Ribosylation Factor 6ADP-Ribosylation FactorsARF6 protein, humanArf6 protein, mouseFibrinogenPlatelet Glycoprotein GPIIb-IIIa Complex

Identifiers

PMID26738539
PMCPMC4797022
OpenAlexW2323022101

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.